abstract |
The present invention provides a 4-((1R, 3S) -6-chloro-3 having activity at the dopamine D 1 and D 2 receptors as well as serotonin 5HT 2 receptors for the treatment of diseases in the central nervous system in a weekly dosing regimen. -Phenyl-indan-1-yl) -1,2,2-trimethyl-piperazine and its salts. |